Ruglim PM 1 Tablet SR
Marketer
Ajuras Pharmaceutical Pvt Ltd
Salt Composition
Glimepiride (1mg) + Metformin (500mg) + Pioglitazone (15mg)
Overview Ruglim PM 1 Tablet SR
Combiflex SR, a single-tablet formulation, manages blood glucose effectively. This medication, used alongside diet and exercise, improves glycemic control in adult type 2 diabetics by enhancing insulin utilization, thus reducing blood sugar. Dosage and duration should strictly adhere to your physician's instructions; administer with food to prevent gastric distress. For missed doses, take immediately unless the next dose is imminent; then, omit the missed dose. Never double the dose; overdose risks hypoglycemia. Concurrent use with other diabetes medications, alcohol, or skipped meals increases hypoglycemia risk; regular blood glucose monitoring is vital. Common adverse effects include nausea, diarrhea, abdominal pain, headache, fractures, and respiratory infections. Disclose kidney, liver, or heart conditions before initiating treatment; pregnant or lactating individuals require physician consultation. Pre-treatment kidney function assessment is standard. Limit alcohol consumption to minimize potential side effects.
Uses of Ruglim PM 1 Tablet SR
Managing type 2 diabetes
Major Benefits of Ruglim PM 1 Tablet SR:
Consume this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment length. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. It's recommended to take one Ruglim PM SR tablet with a meal.
Common Side effects of Ruglim PM 1 Tablet SR:
- Hypoglycemia (low blood glucose level)
- Headache
- Nausea
- Diarrhea
- Dizziness
- Vomiting
- Anemia (low number of red blood cells)
- Weakness
- Sinus infection
How to use Ruglim PM 1 Tablet SR:
Consume this medication precisely as directed by your physician, adhering to the prescribed dosage and schedule. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. It's recommended to take Ruglim PM 1 Tablet SR with a meal.
How Ruglim PM 1 Tablet SR works:
Ruglim PM 1 Tablet SR combines glimepiride, metformin, and pioglitazone—three distinct antidiabetic agents—to optimize blood sugar management when monotherapy or dual therapy proves insufficient. Glimepiride, a sulfonylurea, stimulates pancreatic insulin release, thus reducing blood glucose levels. Metformin, a biguanide, acts through multiple pathways: decreasing hepatic glucose production, slowing intestinal glucose absorption, and enhancing insulin sensitivity. Pioglitazone, a thiazolidinedione, further improves insulin responsiveness.
SAFETY ADVICE
AlcoholUNSAFE
Consuming alcohol alongside Ruglim PM 1 Tablet SR is inadvisable.
PregnancyCONSULT YOUR DOCTOR
The use of Ruglim PM 1 Tablet SR during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to the fetus. A physician will assess the potential advantages against any risks prior to prescribing. Consult your doctor for advice.
Breast feedingCONSULT YOUR DOCTOR
The extended-release Ruglim PM 1 Tablet formulation likely poses a risk to breastfeeding infants. Available human data indicates potential transfer of the medication into breast milk, potentially causing harm to the nursing child.
DrivingCAUTION
Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these blood sugar imbalances.
KidneyCAUTION
Exercise caution when administering Ruglim PM 1 Tablet SR to individuals with impaired renal function; dosage modification may be necessary. Physician consultation is advised. Ruglim PM 1 Tablet SR is contraindicated in patients exhibiting severe kidney disease. Routine monitoring of kidney function is recommended during treatment.
LiverCAUTION
Patients with liver impairment should use Ruglim PM 1 Tablet SR cautiously, potentially requiring dosage modification. Consult a physician before use. Ruglim PM 1 Tablet SR is contraindicated in patients exhibiting severe hepatic dysfunction.
What if you forget to take Ruglim PM 1 Tablet SR :
Should you forget to take a Ruglim PM 1 Tablet SR, administer it immediately upon remembering. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Ruglim PM 1 Tablet SR
| Label | Value |
|---|---|
| Addictive | None. |
| Medication Classification | Medication for diabetes |


